Results 191 to 200 of about 61,737 (200)

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

Lancet, The, 2015
Mark S Sulkowski, Jan Gerstoft, John M Vierling   +2 more
exaly  

Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.

Gastroenterology, 2016
V. L. Dao Thi, Y. Debing, Xianfang Wu, C. Rice, J. Neyts, D. Moradpour, J. Gouttenoire   +6 more
semanticscholar   +1 more source

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

Lancet, The, 2015
Eric Lawitz, Brian L Pearlman, Dominique Guyader   +2 more
exaly  

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

New England Journal of Medicine, 2009
Mark S Sulkowski
exaly  

Ribavirin

Reactions Weekly, 2011
openaire   +1 more source

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

Lancet, The, 2001
exaly  

Ribavirin.

Neonatal network : NN, 1994
openaire   +1 more source

Ribavirin

Reactions Weekly, 1995
openaire   +1 more source

Ribavirin

Reactions, 1989
openaire   +1 more source